Immunogen
$31.23
56
+$0+0% Friday 21:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
28FebExpected
Expected EPS
0.12
Actual EPS
N/A
Financials
-204.93%Profit Margin
Unprofitable108.78MRevenue
-222.93MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IMGN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and IMGN632, a CD123-targeting ADC that is in Phase I clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm. Its preclinical program include IMGC936, an investigational ADC in co-development with MacroGenics, Inc. ImmunoGen, Inc. has collaborations with Roche; Amgen/Oxford BioTherapeutics; sanofi-aventis U. S. LLC; Biotest AG; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Takeda Pharmaceutical Company Limited; Fusion Pharmaceuticals Inc.; Debiopharm International SA; Jazz Pharmaceuticals Ireland Limited; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
Show more...
CEO
Mark Enyedy
Employees
79
Country
US
ISIN
US45253H1014
WKN
000878613
Listings
0 Comments
Share your thoughts
FAQ
What is Immunogen stock price today?▼
The current price of IMGN is $31.23 USD — it has increased by +0% in the past 24 hours. Watch Immunogen stock price performance more closely on the chart.
What is Immunogen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Immunogen stocks are traded under the ticker IMGN.
What is Immunogen revenue for the last year?▼
Immunogen revenue for the last year amounts to 108.78M USD.
What is Immunogen net income for the last year?▼
IMGN net income for the last year is -222.93M USD.
How many employees does Immunogen have?▼
As of April 06, 2026, the company has 79 employees.
In which sector is Immunogen located?▼
Immunogen operates in the Manufacturing sector.
When did Immunogen complete a stock split?▼
Immunogen has not had any recent stock splits.
Where is Immunogen headquartered?▼
Immunogen is headquartered in Boston, US.